Nahdi Medical Company (4164.SR)
SAR 120.8
(0.0%)
SAR 120.8
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 8.71 Billion | 8.61 Billion | 8.06 Billion | 8.64 Billion | 7.82 Billion | 7.35 Billion |
| Cost of Revenue | 5.19 Billion | 5.09 Billion | 4.76 Billion | 5.76 Billion | 5.85 Billion | 5.41 Billion |
| Gross Profit | 3.52 Billion | 3.52 Billion | 3.3 Billion | 2.87 Billion | 1.96 Billion | 1.93 Billion |
| Operating Expenses | 2.47 Billion | 2.53 Billion | 2.43 Billion | 1.92 Billion | 1.15 Billion | 1.26 Billion |
| Selling, General and Administrative Expenses | 1.97 Billion | 421.42 Million | 387.88 Million | 1.79 Billion | 1.16 Billion | 1.26 Billion |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | -23.92 Million | 4.45 Million | 10.02 Million | -126.14 Million | 11.53 Million | 1.21 Million |
| Cost and Expenses | 7.75 Billion | 7.63 Billion | 7.19 Billion | 7.68 Billion | 7.01 Billion | 6.68 Billion |
| Operating Income | 960.95 Million | 1 Billion | 919.56 Million | 959.27 Million | 812.81 Million | 667.49 Million |
| Interest Expense | 83.02 Million | 79.37 Million | 78.88 Million | 57.49 Million | 55.35 Million | - |
| Income Tax Expense | 51.62 Million | 50.11 Million | 44.73 Million | 45.33 Million | 76.62 Million | 28.14 Million |
| Earnings before Tax | 944.24 Million | 937.92 Million | 857.26 Million | 894.44 Million | 768.63 Million | 638.79 Million |
| Net Income | 892.61 Million | 887.81 Million | 812.52 Million | 849.11 Million | 692 Million | 610.65 Million |
| Earnings Per Share Basic | 6.87 | 6.83 | 6.25 | 6.53 | 5.32 | 4.70 |
| Earnings Per Share Diluted | 6.87 | 6.83 | 6.25 | 6.53 | 5.32 | 4.70 |
| Weighted Average Shares Outstanding | 130 Million | 130 Million | 130 Million | 130 Million | 130 Million | 130 Million |
| Weighted Average Shares Outstanding (Diluted) | 130 Million | 130 Million | 130 Million | 130 Million | 130 Million | 130 Million |
| Gross Margin | 0.40 | 0.41 | 0.41 | 0.33 | 0.25 | 0.26 |
| EBIT Margin | 0.19 | 0.19 | 0.18 | 0.17 | 0.17 | 0.11 |
| Profit Margin | 0.10 | 0.10 | 0.10 | 0.10 | 0.09 | 0.08 |
| EBITDA | 1.64 Billion | 1.61 Billion | 1.5 Billion | 1.47 Billion | 1.31 Billion | 788.64 Million |
| Earnings Before Tax Margin | 0.11 | 0.12 | 0.11 | 0.11 | 0.10 | 0.09 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 2.35 Billion | 2.47 Billion | 2.25 Billion | 2.21 Billion | 8.71 Billion | 2.16 Billion |
| Cost of Revenue | 1.5 Billion | 1.53 Billion | 1.4 Billion | 1.34 Billion | 5.19 Billion | 1.28 Billion |
| Gross Profit | 851 Million | 938.7 Million | 854.65 Million | 865.06 Million | 3.52 Billion | 874.17 Million |
| Operating Expenses | 675.2 Million | 665.3 Million | 623.01 Million | 702.78 Million | 2.56 Billion | 644.39 Million |
| Selling, General and Administrative Expenses | - | 671.09 Million | 631.44 Million | -1.44 Billion | - | 651.73 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | -675.2 Million | -665.3 Million | 8.43 Million | 3.77 Million | -2.56 Billion | 216.25 Thousand |
| Cost and Expenses | 2.17 Billion | 2.19 Billion | 2.02 Billion | 1.34 Billion | 7.75 Billion | 1.93 Billion |
| Operating Income | 175.8 Million | 273.4 Million | 231.63 Million | 865.06 Million | 961 Million | 229.77 Million |
| Interest Expense | - | 27.22 Million | 24.61 Million | -6.51 Million | 50.46 Million | 20.42 Million |
| Income Tax Expense | -182.2 Million | 12.87 Million | 9.38 Million | 12.08 Million | 51.62 Million | 9.79 Million |
| Earnings before Tax | - | 260.6 Million | 242.33 Million | 182.6 Million | 944.24 Million | 222.6 Million |
| Net Income | 182.2 Million | 247.73 Million | 232.94 Million | 170.51 Million | 892.61 Million | 212.8 Million |
| Earnings Per Share Basic | 1.40 | 1.91 | 1.79 | 1.31 | - | 1.64 |
| Earnings Per Share Diluted | 1.40 | 1.91 | 1.79 | 1.31 | - | 1.64 |
| Weighted Average Shares Outstanding | 130 Million | 130 Million | 130 Million | 130 Million | 130 Million | 130 Million |
| Weighted Average Shares Outstanding (Diluted) | 130 Million | 130 Million | 130 Million | 130 Million | 130 Million | 130 Million |
| Gross Margin | 0.36 | 0.38 | 0.38 | 0.39 | 0.40 | 0.40 |
| EBIT Margin | 0.07 | 0.19 | 0.17 | 0.14 | - | 0.18 |
| Profit Margin | 0.08 | 0.10 | 0.10 | 0.08 | 0.10 | 0.10 |
| EBITDA | 175.8 Million | 462.95 Million | 393.61 Million | 315.22 Million | - | 396.1 Million |
| Earnings Before Tax Margin | 0.07 | 0.11 | 0.10 | 0.39 | 0.11 | 0.11 |
4375
ALTG-PA
GNGBY
BLSP
MLS
0R4Y